/24-7PressRelease.com/ - March 23, 2005 - PRICING, REIMBURSEMENT AND PARALLEL TRADE 2005 will take place on May 25th and 26th in London. The conference will begin May 25th with opening remarks from the conference chairman, Christopher Teale from Allergan.
The 3rd Annual Pricing, Reimbursement and Parallel Trade 2005 will focus on the current trends and update you on issues surrounding PandR, with a special scope on the latest parallel trade developments. In the light of new technologies being developed, pharmaceutical companies are constantly looking for ways to improve their products' competitiveness in the parallel trading grounds. A unique case study by representatives from Pfizer will address the company's latest proposal to implement the new RFID technology in all their products, to facilitate parallel trade in a more secured environment and to avoid counterfeiting in developing countries.
The variations in PandR policies between Europe and North America have already produced a huge gap, leading to a range of controversial issues. This event will explore the pricing and reimbursement environments in Albania, Bulgaria, Croatia, Macedonian, Siberia, Montenegro and Turkey. Discussions of PandR case studies in Germany, Italy, Spain, Ireland will also be examined. With the enlarged Europe and the rising Asian markets, discover how best to manipulate systems to develop the most cost-effective PandR strategy. Find out how can you benefit from market variations and succeed in the evolving parallel trading grounds.
Companies and organisations participating in the conference program:
- William Haddad, Chairman / CEO, Biogenerics and Active Volunteer, Cipla
- Julian Mount and Martin Sweeney, Senior Director of European Trade and European External Affairs Manager, Pfizer
- Dr. Paul Langley, Manager, Health Economic, 3M and Adjunct Professor, College of Pharmacy, University of Minnesota
- Jie Shen, Head, Pricing, Health Outcome, Access and Key Account Management, Eli Lilly
- Grant Maclaine, Head, Reimbursement and TA Metabolic, Global Health Economics and Outcomes Research, Bayer
- Tomasz Dzitko, Director, Delfarma
- Oliver Schwerdt, Pricing Policy and Controlling, Region Europe, Schering AG
- Kevin Loth, Director, European Public Affairs, Novartis
- Chris Teale, Director Health Economics, Pricing, Reimbursment and Product Access, Allergan
- Dr. Boyan Doganov, Director, International Projects, The International Health Care and Health - Insurance Research Institute
- Dr. Silvio Garratini, Director, Mario Negri Institute
- Michael Barry, Clinical Director, National Centre for Pharmacoeconomics, St James Hospital
Complementing this conference, is a pre-conference interactive workshop consisting of two stimulating sessions (Tuesday 24th May 2005) entitled:
ASSESSING THE PRICING POTENTIAL BY A PRICING MATRIX MODEL
which will be led by:
Mark Nuijten, VP, Business Development and Senior Research Scientist, MedTap
EXPLORE NOVEL PRICING and REIMBURSEMENT STRATEGIES IN EUROPE
that will be led by:
Klaus Hilleke, Senior Partner, Simon-Kuchers and Partner
For more information about this event, please visit:
http://www.b2b-conferences.com/Pharmaceuticals/168/3rd-Annual-Pricing,-Reimbursement-and-Parallel-Trade-2005.html
# # #
About B2B Conferences:
B2B Conferences is one of Europe's fastest growing media companies today, basing its knowledge on the raft of management reports and industry news letter that the parent company produces each year. B2B Conferences has built up a solid reputation for putting together high quality business to business event workshops aimed at the corporate community.
These events are unique in that B2B operates on a wholly independent basis, therefore producing conferences that are timely, targeted and at time controversial, giving delegates, speakers and sponsors alike, the opportunity to get a totally unbiased view of their industry.
For more conference information, please contact our website on: http://www.b2b-conferences.com
For information on visiongain, please visit the website: http://www.visiongain.com
For additional information contact:
Senh Ip
Corporate communications
Tel: +44 (0) 20 8767 6711
Fax: +44 (0) 20 8767 5001
Email: Senh.ip@visiongain.com
Corporate tables and sponsorship/exhibitor opportunities are still available; please call the hotline or email Andrew.oliver@visiongain.com for more information.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. Based in London, UK, visiongain produce a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and currently the Defence sector.
Visiongain publish reports produced by their in-house analysts of qualified experts in their field. Visiongain have firmly established themselves as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
Visiongain also have an event division, b2b Conferences, works in tandem with their analytical reports to provide a forum for key issues within the Telecoms and Pharmaceutical professionals.
For information on visiongain, please visit the website: http://www.visiongain.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Senh Ip:
